Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of DKK 4.16 trillion. The enterprise value is 4.15 trillion.
Market Cap | 4.16T |
Enterprise Value | 4.15T |
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | Aug 15, 2024 |
Share Statistics
Novo Nordisk has 4.43 billion shares outstanding. The number of shares has decreased by -0.90% in one year.
Shares Outstanding | 4.43B |
Shares Change (YoY) | -0.90% |
Shares Change (QoQ) | -0.11% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 33.40% |
Float | 3.17B |
Valuation Ratios
The trailing PE ratio is 46.71 and the forward PE ratio is 36.53. Novo Nordisk's PEG ratio is 1.59.
PE Ratio | 46.71 |
Forward PE | 36.53 |
PS Ratio | 16.23 |
PB Ratio | 37.16 |
P/FCF Ratio | 51.25 |
PEG Ratio | 1.59 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.48, with an EV/FCF ratio of 51.18.
EV / Earnings | 46.20 |
EV / Sales | 16.10 |
EV / EBITDA | 32.48 |
EV / EBIT | 35.01 |
EV / FCF | 51.18 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 50.71.
Current Ratio | 0.94 |
Quick Ratio | 0.74 |
Debt / Equity | 50.71 |
Debt / EBITDA | 0.45 |
Debt / FCF | 0.70 |
Interest Coverage | 218.77 |
Financial Efficiency
Return on equity (ROE) is 88.57% and return on invested capital (ROIC) is 51.87%.
Return on Equity (ROE) | 88.57% |
Return on Assets (ROA) | 22.80% |
Return on Capital (ROIC) | 51.87% |
Revenue Per Employee | 3.73M |
Profits Per Employee | 1.30M |
Employee Count | 64,319 |
Asset Turnover | 0.79 |
Inventory Turnover | 1.24 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.67% in the last 52 weeks. The beta is 0.13, so Novo Nordisk's price volatility has been lower than the market average.
Beta (5Y) | 0.13 |
52-Week Price Change | +45.67% |
50-Day Moving Average | 929.56 |
200-Day Moving Average | 848.69 |
Relative Strength Index (RSI) | 56.42 |
Average Volume (20 Days) | 2,713,362 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of DKK 258.00 billion and earned 89.90 billion in profits. Earnings per share was 20.08.
Revenue | 258.00B |
Gross Profit | 218.09B |
Operating Income | 118.57B |
Pretax Income | 112.93B |
Net Income | 89.90B |
EBITDA | 126.56B |
EBIT | 118.57B |
Earnings Per Share (EPS) | 20.08 |
Balance Sheet
The company has 62.65 billion in cash and 57.06 billion in debt, giving a net cash position of 5.59 billion or 1.26 per share.
Cash & Cash Equivalents | 62.65B |
Total Debt | 57.06B |
Net Cash | 5.59B |
Net Cash Per Share | 1.26 |
Equity (Book Value) | 112.52B |
Book Value Per Share | 25.24 |
Working Capital | -10.41B |
Cash Flow
In the last 12 months, operating cash flow was 115.33 billion and capital expenditures -34.18 billion, giving a free cash flow of 81.16 billion.
Operating Cash Flow | 115.33B |
Capital Expenditures | -34.18B |
Free Cash Flow | 81.16B |
FCF Per Share | 18.30 |
Margins
Gross margin is 84.53%, with operating and profit margins of 45.96% and 34.84%.
Gross Margin | 84.53% |
Operating Margin | 45.96% |
Pretax Margin | 43.77% |
Profit Margin | 34.84% |
EBITDA Margin | 49.05% |
EBIT Margin | 45.96% |
FCF Margin | 31.46% |
Dividends & Yields
This stock pays an annual dividend of 9.40, which amounts to a dividend yield of 1.02%.
Dividend Per Share | 9.40 |
Dividend Yield | 1.02% |
Dividend Growth (YoY) | 39.93% |
Years of Dividend Growth | 6 |
Payout Ratio | 46.71% |
Buyback Yield | 0.90% |
Shareholder Yield | 1.92% |
Earnings Yield | 2.14% |
FCF Yield | 1.95% |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
Last Split Date | Sep 13, 2023 |
Split Type | Forward |
Split Ratio | 2 |